Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR)

Edward B. Weiser, Thomas W. Burke, Paul B. Heller, Joan Woodward, William J. Hoskins, Robert C. Park

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

In an attempt to identify those parameters which represent predictors of clinical outcome, a retrospective review of patients with epithelial ovarian carcinoma who were primarily treated with whole abdominal irradiation (WAR) following staging laparotomy was performed. Complete records with extensive long-term follow-up were available on 102 patients treated from 1962 through 1974. Histopathologic review excluded 18 patients with lesions of low malignant potential. Of the remaining 84 cases there were 12 Stage I (14%), 23 Stage II (27%), 45 Stage III (54%), and 4 Stage IV (5%). Measure of completeness of surgical resection was expressed as the largest diameter of residual gross tumor. Following primary surgical debulking of Stages II and III patients, 24 patients had no gross residual disease, 24 patients had less than 2 cm of residual disease, and 20 patients had greater than 2 cm of residual disease. For Stages II and III patients together, 5- and 10-year actuarial survivals were: No gross residual, 69% and 59%; less than 2 cm, 48% and 42%; and greater than 2 cm, 15% and 10%. The technique of administration of WAR did not appear to influence survival. The results of this review support the concept that in selecting WAR for primary treatment of ovarian carcinoma, completeness of cytoreductive surgery should be considered. These data justify a prospective randomized study in patients with minimal residual disease following staging laparotomy comparing WAR with current first-line combination chemotherapy.

Original languageEnglish (US)
Pages (from-to)201-208
Number of pages8
JournalGynecologic Oncology
Volume30
Issue number2
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Abdomen
Carcinoma
Survival
Residual Neoplasm
Laparotomy
Combination Drug Therapy
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

Weiser, Edward B. ; Burke, Thomas W. ; Heller, Paul B. ; Woodward, Joan ; Hoskins, William J. ; Park, Robert C. / Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). In: Gynecologic Oncology. 1988 ; Vol. 30, No. 2. pp. 201-208.
@article{57b8d9405c804fe597630518eee42135,
title = "Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR)",
abstract = "In an attempt to identify those parameters which represent predictors of clinical outcome, a retrospective review of patients with epithelial ovarian carcinoma who were primarily treated with whole abdominal irradiation (WAR) following staging laparotomy was performed. Complete records with extensive long-term follow-up were available on 102 patients treated from 1962 through 1974. Histopathologic review excluded 18 patients with lesions of low malignant potential. Of the remaining 84 cases there were 12 Stage I (14{\%}), 23 Stage II (27{\%}), 45 Stage III (54{\%}), and 4 Stage IV (5{\%}). Measure of completeness of surgical resection was expressed as the largest diameter of residual gross tumor. Following primary surgical debulking of Stages II and III patients, 24 patients had no gross residual disease, 24 patients had less than 2 cm of residual disease, and 20 patients had greater than 2 cm of residual disease. For Stages II and III patients together, 5- and 10-year actuarial survivals were: No gross residual, 69{\%} and 59{\%}; less than 2 cm, 48{\%} and 42{\%}; and greater than 2 cm, 15{\%} and 10{\%}. The technique of administration of WAR did not appear to influence survival. The results of this review support the concept that in selecting WAR for primary treatment of ovarian carcinoma, completeness of cytoreductive surgery should be considered. These data justify a prospective randomized study in patients with minimal residual disease following staging laparotomy comparing WAR with current first-line combination chemotherapy.",
author = "Weiser, {Edward B.} and Burke, {Thomas W.} and Heller, {Paul B.} and Joan Woodward and Hoskins, {William J.} and Park, {Robert C.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/0090-8258(88)90025-X",
language = "English (US)",
volume = "30",
pages = "201--208",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR). / Weiser, Edward B.; Burke, Thomas W.; Heller, Paul B.; Woodward, Joan; Hoskins, William J.; Park, Robert C.

In: Gynecologic Oncology, Vol. 30, No. 2, 01.01.1988, p. 201-208.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR)

AU - Weiser, Edward B.

AU - Burke, Thomas W.

AU - Heller, Paul B.

AU - Woodward, Joan

AU - Hoskins, William J.

AU - Park, Robert C.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - In an attempt to identify those parameters which represent predictors of clinical outcome, a retrospective review of patients with epithelial ovarian carcinoma who were primarily treated with whole abdominal irradiation (WAR) following staging laparotomy was performed. Complete records with extensive long-term follow-up were available on 102 patients treated from 1962 through 1974. Histopathologic review excluded 18 patients with lesions of low malignant potential. Of the remaining 84 cases there were 12 Stage I (14%), 23 Stage II (27%), 45 Stage III (54%), and 4 Stage IV (5%). Measure of completeness of surgical resection was expressed as the largest diameter of residual gross tumor. Following primary surgical debulking of Stages II and III patients, 24 patients had no gross residual disease, 24 patients had less than 2 cm of residual disease, and 20 patients had greater than 2 cm of residual disease. For Stages II and III patients together, 5- and 10-year actuarial survivals were: No gross residual, 69% and 59%; less than 2 cm, 48% and 42%; and greater than 2 cm, 15% and 10%. The technique of administration of WAR did not appear to influence survival. The results of this review support the concept that in selecting WAR for primary treatment of ovarian carcinoma, completeness of cytoreductive surgery should be considered. These data justify a prospective randomized study in patients with minimal residual disease following staging laparotomy comparing WAR with current first-line combination chemotherapy.

AB - In an attempt to identify those parameters which represent predictors of clinical outcome, a retrospective review of patients with epithelial ovarian carcinoma who were primarily treated with whole abdominal irradiation (WAR) following staging laparotomy was performed. Complete records with extensive long-term follow-up were available on 102 patients treated from 1962 through 1974. Histopathologic review excluded 18 patients with lesions of low malignant potential. Of the remaining 84 cases there were 12 Stage I (14%), 23 Stage II (27%), 45 Stage III (54%), and 4 Stage IV (5%). Measure of completeness of surgical resection was expressed as the largest diameter of residual gross tumor. Following primary surgical debulking of Stages II and III patients, 24 patients had no gross residual disease, 24 patients had less than 2 cm of residual disease, and 20 patients had greater than 2 cm of residual disease. For Stages II and III patients together, 5- and 10-year actuarial survivals were: No gross residual, 69% and 59%; less than 2 cm, 48% and 42%; and greater than 2 cm, 15% and 10%. The technique of administration of WAR did not appear to influence survival. The results of this review support the concept that in selecting WAR for primary treatment of ovarian carcinoma, completeness of cytoreductive surgery should be considered. These data justify a prospective randomized study in patients with minimal residual disease following staging laparotomy comparing WAR with current first-line combination chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0023896109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023896109&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(88)90025-X

DO - 10.1016/0090-8258(88)90025-X

M3 - Article

C2 - 3371745

AN - SCOPUS:0023896109

VL - 30

SP - 201

EP - 208

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -